| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Griffin CE | |
| Hillier A | |||
| P2860 | cites work | Immunotherapy with cat- and dog-dander extracts. V. Effects of 3 years of treatment | Q28276515 |
| Mechanisms of allergen-specific immunotherapy | Q33945896 | ||
| Immunotherapy in atopic dermatitis | Q34104585 | ||
| Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. | Q34170327 | ||
| Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper | Q34754637 | ||
| Advances in methodology for diagnosis of allergic skin disease | Q38003905 | ||
| Long-term management of atopic disease in the dog. | Q38003917 | ||
| The clinical and immunologic specificity of immunotherapy | Q39491716 | ||
| Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy. | Q39820008 | ||
| Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells | Q40749921 | ||
| Antibody response following immunotherapy in ragweed hay fever: Allpyral vs. whole ragweed extract | Q40950686 | ||
| A Double-Blind Study of the Effectiveness and Specificity of Injection Therapy in Ragweed Hay Fever | Q40964752 | ||
| TREATMENT OF RAGWEED HAY FEVER WITH ALLPYRAL EXTRACTS. | Q40966823 | ||
| Monoclonal antibody-standardized cat extract immunotherapy: risk-benefit effects from a double-blind placebo study | Q41040677 | ||
| Recent developments in the treatment of atopic eczema | Q41515137 | ||
| Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis | Q43558341 | ||
| Effect of immunotherapy on the serum concentrations of allergen-specific IgG antibodies in dog sera | Q44458652 | ||
| Retrospective survey of allergen immunotherapy in canine atopy. | Q50868184 | ||
| PROPHYLACTIC INOCULATION AGAINST HAY FEVER | Q57255078 | ||
| FURTHER OBSERVATIONS ON THE TREATMENT OF HAY FEVER BY HYPODERMIC INOCULATIONS OF POLLEN VACCINE | Q57255080 | ||
| Specific hyposensitization in atopic dermatitis | Q66991398 | ||
| Specific immunotherapy with a standardized Dermatophagoides pteronyssinus extract. II. Prediction of efficacy of immunotherapy | Q67990755 | ||
| A double-blind controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with atopic eczema | Q68167037 | ||
| The nasal response to histamine challenge: Effect of the pollen season and immunotherapy+§ | Q68204924 | ||
| Suppression of the late cutaneous response by immunotherapy | Q69939739 | ||
| Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts | Q70232271 | ||
| A novel therapy for atopic dermatitis with allergen-antibody complexes: a double-blind, placebo-controlled study | Q70560174 | ||
| Atopic disease in the dog | Q70565725 | ||
| A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects | Q70615175 | ||
| The effect of alum concentration on the repository and adjuvant properties of alum-precipitated antigens | Q70891641 | ||
| Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study | Q71120253 | ||
| Effect of preservatives and conditions of storage on the potency of allergy extracts | Q71441064 | ||
| Successful hyposensitization treatment in atopic eczema: results of a trial in monozygotic twins | Q71443674 | ||
| Effect on humoral tolerance (IgG and IgE) in dogs by oral administration of ovalbumin and Der p I | Q72063613 | ||
| The use of alum precipitated pyridine pollen extract in the treatment of ragweed pollinosis | Q72602614 | ||
| Position paper: Immunotherapy | Q72860301 | ||
| Rush immunotherapy in a dog with severe ragweed and grass pollen allergy | Q73043910 | ||
| Comparison of response to immunotherapy by intradermal skin test and antigen-specific IgE in canine atopy | Q73096989 | ||
| Pilot study of IFN-gamma-induced specific hyposensitization for house dust mites in atopic dermatitis: IFN-gamma-induced immune deviation as a new therapeutic concept for atopic dermatitis | Q73904587 | ||
| Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis | Q74309230 | ||
| Immunologic changes associated with allergen immunotherapy | Q77178347 | ||
| The clinical evaluation and the preparation and standardization of suspensions of a new water-insoluble whole ragweed pollen complex | Q78515216 | ||
| Suppression of late-phase skin reactions by immunotherapy with ragweed extract | Q93634268 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | atopic dermatitis | Q268667 |
| immunotherapy | Q1427096 | ||
| P304 | page(s) | 363-383 | |
| P577 | publication date | 2001-09-01 | |
| P1433 | published in | Veterinary Immunology and Immunopathology | Q7923704 |
| P1476 | title | The ACVD task force on canine atopic dermatitis (XXIV): allergen-specific immunotherapy | |
| P478 | volume | 81 |
| Q47991624 | A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis |
| Q42961088 | Agreement between allergen-specific IgE assays and ensuing immunotherapy recommendations from four commercial laboratories in the USA. |
| Q34502300 | An update on the treatment of canine atopic dermatitis |
| Q57482859 | Atopic dermatitis in cats and dogs: a difficult disease for animals and owners |
| Q37514837 | Canine models of atopic dermatitis: a useful tool with untapped potential |
| Q54191364 | Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study. |
| Q36241326 | Effectiveness of regionally-specific immunotherapy for the management of canine atopic dermatitis |
| Q83186989 | Evaluation of subcutaneous versus mucosal (intranasal) allergen-specific rush immunotherapy in experimental feline asthma |
| Q28196384 | Evidence-based veterinary dermatology: a systematic review of the pharmacotherapy of canine atopic dermatitis |
| Q36530270 | House dust and forage mite allergens and their role in human and canine atopic dermatitis |
| Q84340803 | Intra and inter-laboratory reproducibility of a monoclonal antibody cocktail based ELISA for detection of allergen specific IgE in dogs: proficiency monitoring of macELISA in six laboratories |
| Q84488087 | Intra- and interlaboratory variability of allergen-specific IgE levels in atopic dogs in three different laboratories using the Fc-epsilon receptor testing |
| Q37171010 | Intradermal injection of Hsp60 induces cytokine responses in canine atopic and healthy skin. |
| Q48255235 | Long-term effects of intralymphatic immunotherapy (ILIT) on canine atopic dermatitis. |
| Q43208450 | Masitinib for the treatment of canine atopic dermatitis: a pilot study |
| Q28650228 | Pollen Allergies in Humans and their Dogs, Cats and Horses: Differences and Similarities |
| Q46651567 | Prevalence of the group 1 Dermatophagoides allergens Der p 1 and Der f 1 in homes with no dogs, healthy dogs and Dermatophagoides-sensitized atopic dogs in Liverpool |
| Q48162780 | Proof of concept of the preventive efficacy of high-dose recombinant mono-allergen immunotherapy in atopic dogs sensitized to the Dermatophagoides farinae allergen Der f 2. |
| Q46540032 | Rush allergen specific immunotherapy protocol in feline atopic dermatitis: a pilot study of four cats |
| Q44780118 | The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs |
| Q46758748 | Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex |
| Q43067638 | Treatment of canine atopic dermatitis: 2010 clinical practice guidelines from the International Task Force on Canine Atopic Dermatitis |
Search more.